Insight Guru Inc.
09/25/2026 | Press release | Distributed by Public on 09/25/2026 01:29
Mid Cap Stocks At 52-Week Highs: Thursday’s Full List
A new list of market highs is heavily weighted toward one part of the economy.
Life Sciences Tools & Services and Biotechnology each placed 3 names on today's list. As of Thursday, September 24, there are 10 Mid Cap US and Canada-listed stocks in the Trefis coverage universe trading at their 52-week highs. The largest of these is Okta (OKTA), with a market value of about $36.4 billion, after its stock gained 58.2% over the last month. When a stock runs that far that fast to a new high, the question becomes what kind of business performance is underneath the price.
Thursday's Full 52-Week-High List
Here are all 10 names, sorted by market capitalization, with returns over four windows:
| Tickers |
Market Cap |
1D % Chg |
1W % Chg |
1M % Chg |
1Y % Chg |
|---|---|---|---|---|---|
| OKTA | $36.4 Bil | 0.6% | 8.7% | 58.2% | 124.1% |
| MTD | $30.57 Bil | 1.8% | 7.7% | 8.3% | 20.9% |
| DT | $17.15 Bil | 0.3% | 5.1% | 17.2% | 22.8% |
| RVTY | $16.81 Bil | 6.0% | 2.7% | 20.7% | 76.3% |
| HALO | $13.51 Bil | 2.5% | 5.1% | 5.4% | 48.5% |
| TWST | $11.48 Bil | 16.1% | 18.3% | 21.5% | 565.8% |
| TECH | $11.33 Bil | 0.1% | 0.2% | 0.3% | 37.9% |
| TXG | $10.93 Bil | 11.2% | 9.3% | 30.0% | 573.4% |
| RGEN | $10.76 Bil | 3.3% | 7.0% | 4.9% | 53.8% |
| FRHC | $10.66 Bil | 2.1% | 7.1% | 3.1% | 2.9% |
This screen covers US and Canada-listed stocks in the Trefis coverage universe. Mid Cap here means a market value between $10 billion and $40 billion, the upper figure excluded.
One name's run is backed by extreme growth and margin.
Halozyme Therapeutics (HALO) shows a case where the business numbers are as striking as the price. The stock trades at 32.7 times trailing earnings. This multiple is based on trailing earnings that include at least one loss quarter, so the multiple is not comparable to a clean-year multiple. Over the last twelve months, its revenue grew 41.2% and its operating margin was 55.9%.
A high price is a question, not an answer.
A list of stocks at their strongest prices of the year is a useful screen for strength. Price leadership often persists. But a 52-week high is a data point, not a verdict on a company's quality or future. The disciplined next step is always the same: to check whether the business fundamentals can earn the new, higher valuation.
Before chasing any name on this list, ask what the company itself expects next. Our Guidance Momentum screen surfaces the stocks whose managements just raised their own outlooks.
New Highs Fade. Discipline Compounds
Some of the names on this list will keep setting highs for years, and some are at the top of their run right now. Sorting one from the other, name by name, every day, is the work most investors never keep up with.
That sorting is what the Trefis High Quality (HQ) Portfolio does systematically: about 30 quality businesses screened for the fundamentals that sustain a run, held with rules instead of excitement. It has a track record of outpacing a benchmark that combines the S&P 500, the S&P MidCap 400, and the Russell 2000. Use the high list for ideas; use the portfolio for the compounding.
Insight Guru Inc. published this content on September 25, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on September 25, 2026 at 07:29 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]